Cyclacel Pharmaceuticals Announces Publication Confirming Fadraciclib Suppresses MCL1 and Synergizes With Venetoclax in Chronic Lymphocytic Leukemia
April 12, 2022 07:00 ET
|
Cyclacel
-New Preclinical Data Highlight Fadraciclib’s Apoptosis Enabling Mechanism in Leukemia- -Remarkable Synergy Observed with Venetoclax, esp. in Resistant CLL cells with 17p Deletion- BERKELEY HEIGHTS,...
Microdea Expands Partnership Ecosystem
July 16, 2020 09:00 ET
|
Microdea Inc.
Leading TMS and telematics providers are integrating with Microdea’s mobile app and cloud-based document management solutions to drive efficiency gains for carriers and brokers. TORONTO, July 16,...
Microdea is Named to the 2017 List of Best Workplaces in Technology
October 03, 2017 11:00 ET
|
Microdea Inc.
MARKHAM, Ontario, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Microdea is proud to announce that our organization has been named to the 2017 LIST OF BEST WORKPLACES IN TECHNOLOGY Microdea received this...
Microdea Makes the PROFIT 500 List for Fourth Consecutive Year
September 14, 2017 09:00 ET
|
Microdea Inc.
MARKHAM, Ontario, Sept. 14, 2017 (GLOBE NEWSWIRE) -- Canadian Business and PROFIT today ranked Microdea No. 457 on the 29th annual PROFIT 500, the definitive ranking of Canada’s Fastest-Growing...